Fig. 1
From: Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma

Schematic illustration of therapeutic mechanism of DOX-CB@lipo-pDNA-iRGD
From: Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
Schematic illustration of therapeutic mechanism of DOX-CB@lipo-pDNA-iRGD